Diethylstilbestrol
⚠️ Warning: High doses of diethylstilbestrol (DES) in early pregnancy have caused
clear cell vaginal carcinoma in female offspring 16–20 years later.
👉 It must never be used in pre-menopausal women.
💊 About
- A synthetic oestrogen, historically prescribed for pregnancy-related issues.
- Withdrawn for most uses due to carcinogenic potential.
- Now only used in the treatment of malignant disease.
- Check BNF here for the latest details.
⚙️ Mode of Action
- Acts as an oestrogen analogue.
- Suppresses testosterone production → useful in androgen-dependent cancers (e.g., prostate carcinoma).
- Also used in certain post-menopausal breast cancers.
🎯 Indications / Dose
- Prostate carcinoma: 1–3 mg daily.
- Post-menopausal breast carcinoma: 10–20 mg daily.
🤝 Interactions
- See BNF for detailed interactions (multiple CYP- and oestrogen-related drug effects).
⚠️ Cautions
- As per BNF – monitor cardiovascular, hepatic, and thrombotic risks carefully.
- Long-term exposure increases malignancy risk.
🚫 Contraindications
- Pregnancy, children.
- Oestrogen-dependent tumours (breast, endometrium).
- Undiagnosed vaginal bleeding, porphyria.
- Moderate–severe hypertension.
- Severe or active liver disease.
- Dyslipidaemia, history of MI, stroke, VTE.
- Sickle cell anaemia, untreated polycythaemia, pulmonary hypertension.
❗ Side Effects
- Gynaecomastia.
- Thromboembolic risk (DVT, PE, stroke).
- Fluid retention, hypertension.
- Nausea, weight gain, reduced libido.
- ⚠️ Clear cell vaginal / cervical carcinoma in offspring exposed in utero.
📚 References